Intelligent Bio Solutions Inc. (NASDAQ: INBS) reported a second-quarter loss per share that exceeded analyst projections as revenue trailed Wall Street estimates.
The company posted adjusted earnings of -$1.58 per share for the period, compared with a consensus forecast of $3.30 per share, resulting in a miss of $4.88 per share. Revenue totaled $1.22 million, falling short of the $8.8 million consensus estimate by $7.58 million.
Shares of INBS traded at $2.67 at the close of regular hours, up 3.89% over the prior three months but down 81.84% year-over-year. In after-hours trading, the stock was down 3.4% following the release.
InvestingPro rated the company’s financial performance as "fair," reflecting a mixed outlook despite recent share gains. The firm did not provide updated guidance in its earnings release.
